Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study

Highlights • We found significant survival differences by country in Europe for haematological malignancies (HM) in 2000’s. • Population-based survival for HM was poorest in Eastern Europe and highest in Central and Northern Europe. • Morphology sub-type, age at diagnosis and, to a lesser extent, gender were relevant prognostic factors. • Survival gaps were largest for chronic myeloid leukaemia and lowest for Hodgkin’s Lymphoma. • Survival gaps were higher for sub-types that benefited more from therapeutic advances.